Propylthiouracil is a pharmaceutical raw material used in the manufacture of thyroid-inhibiting medications. It is a sulfur-containing heterocyclic compound with moderate lipophilicity and two hydrogen-bond donor sites.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Restricted or banned substances
Substances on this list are banned or restricted under the named regulation. This page is a compliance reference — verify your obligations under applicable law.
CAS 51-52-5
(±)-hyoscyamine
pharmaceutical raw material
Homatropine hydrobromide
pharmaceutical raw material
Neostigmine methylsulfate
pharmaceutical raw material
Dopamine
pharmaceutical raw material
Methylthiouracil
pharmaceutical raw material
4-Hydroxy-5-methyl-2-mercaptopyrimidine
pharmaceutical intermediate
4-Amino-6-hydroxy-2-mercaptopyrimidine monohydrate
research compound
2-Thiouracil
pharmaceutical raw material
The international HS code for Propylthiouracil (CAS 51-52-5) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
6-propyl-2-sulfanylidene-1H-pyrimidin-4-one
KNAHARQHSZJURB-UHFFFAOYSA-N
CCCC1=CC(=O)NC(=S)N1